Circulating tumor DNA and radiological tumor volume identify patients at risk for relapse with resected, early-stage non-small-cell lung cancer.

导出 OA

翻译打印收藏纠错

第一作者： H T,Tran

第一单位： Department of Thoracic Head & Neck Medical Oncology.

作者： H T,Tran ^[1] ; S,Heeke ^[1] ; S,Sujit ^[2] ; N,Vokes ^[1] ; J,Zhang ^[1] ; M,Aminu ^[2] ; V K,Lam ^[3] ; A,Vaporciyan ^[4] ; S G,Swisher ^[4] ; M C B,Godoy ^[5] ; T,Cascone ^[1] ; B,Sepesi ^[1] ; D L,Gibbons ^[1] ; J,Wu ^[6] ; J V,Heymach ^[7]

作者单位： Department of Thoracic Head & Neck Medical Oncology. ^[1] Department of Imaging Physics, The University of Texas MD Anderson Cancer Center, Houston. ^[2] Department of Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins, Baltimore. ^[3] Department of Thoracic and Cardiovascular Surgery. ^[4] Department of Thoracic Imaging, The University of Texas MD Anderson Cancer Center, Houston, USA. ^[5] Department of Thoracic Head & Neck Medical Oncology; Department of Imaging Physics, The University of Texas MD Anderson Cancer Center, Houston. ^[6] Department of Thoracic Head & Neck Medical Oncology. Electronic address: jheymach@mdanderson.org. ^[7]

关键词 MRD ctDNA early-stage NSCLC liquid biopsy tumor volume

主题词人类(Humans);癌, 非小细胞肺(Carcinoma, Non-Small-Cell Lung);肺肿瘤(Lung Neoplasms);肿瘤负荷(Tumor Burden);突变(Mutation);小细胞肺癌(Small Cell Lung Carcinoma);复发(Recurrence)

DOI 10.1016/j.annonc.2023.11.008

PMID 37992871

发布时间 2025-02-02

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交